Guardant Health
GH
#1677
Rank
A$18.44 B
Marketcap
A$142.00
Share price
-7.34%
Change (1 day)
86.49%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

EPS for Guardant Health (GH)

EPS in 2025 (TTM): A-$5.02

According to Guardant Health 's latest financial reports the company's current EPS (TTM) is A-$4.63. In 2024 the company made an earnings per share (EPS) of A-$5.14 an increase over its 2023 EPS that were of A-$6.18.

EPS history for Guardant Health from 2018 to 2025

Annual EPS

Year EPS Change
2025 (TTM)A-$5.02-2.4%
2024A-$5.14-16.82%
2023A-$6.18-33.13%
2022A-$9.2460%
2021A-$5.7755.04%
2020A-$3.72207.14%
2019A-$1.21-19.81%
2018A-$1.51

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Neogen
NEOG
A-$4.00-13.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Natera
NTRA
A-$3.09-33.33%๐Ÿ‡บ๐Ÿ‡ธ USA